Now I have sufficient calibration data. Let me produce the final review.

**Round-1 bracket:** I compared against anchors in the 1.5-3.5 band (avg 3.0), the 3.5-5.5 band (3.75-4.33), and the 5.5-7.5 band (5.6-6.75). The most topically similar anchors are "Revisiting the Scaling Effects of LLMs on Medical Reasoning Capabilities" (4.00) and "Enhancing Clinical Note Summarization" (4.25). Both have methodological concerns that anchor them in the 4.0 range. Our paper has a more fundamental methodological flaw (comparison fairness) but also one genuinely strong contribution (Collapse Analysis, weight=9.42). The paper does not reach the 5.5-7.5 band where papers like "Enhancing Small Medical Learners" (6.00) sit — those have cleaner methodology and stronger evidence overall. The bracket is 3.5–5.0.

**Final score:** 4.0. The most severe weakness (comparison fairness, weight=-0.49) places this paper below well-executed evaluation studies, but the Collapse Analysis (weight=9.42) and zero-shot results prevent it from falling into the strong-reject band.

---

## Summary

This paper evaluates small LMs (≤3B parameters) against larger, medically-adapted LMs/VLMs on clinical text summarization (MeQSum) and radiology report generation (MIMIC-CXR) using both in-context learning and PEFT methods. The core contributions are a within-family "Collapse Analysis" identifying a safety threshold around 1B parameters where hallucination rates spike, and the contrast between text-only summarization (where small models can be competitive) and vision-language reporting (where small VLMs consistently lag).

## Strengths

- **The within-family Collapse Analysis across model scales (Table 3) is genuinely informative.** It shows hallucination rates spiking from ~2–3% at 1.7B+ to 18–75% below 360M parameters, identifying a memorable "safety collapse" threshold. This is the paper's most robust and distinctive finding. [weight=9.42]
- **The research question is practically important and well-motivated (Section 1).** The paper asks whether small models can substitute for large ones in clinical NLP — a question with direct implications for privacy, cost, and on-premise deployment. [weight=7.25]
- **Contrasting text-only and vision-language tasks within the same study is useful.** The finding that SLMs can approach large LM performance on text summarization (under fair comparison) while SVLMs consistently lag in radiology reporting differentiates this paper from single-modality studies. [weight=7.50]

## Weaknesses

### Major

- **Central comparison is structurally unfair: LoRA-tuned small models vs. ICL-only large models.** In the fine-tuning experiments (Section 3.2, Figure 3), small LMs (Llama 3.2, Gemma 3, SmolLM2) are evaluated both with ICL and after LoRA fine-tuning, while the large LMs (BioMistral, Med-LLaMA, OpenBioLLM) are evaluated *only* with ICL — they have no LoRA column. The paper then claims "LoRA-tuned Gemma-3 (1B) outperforms all large LMs" (line 191) and "After LoRA fine-tuning, all small LMs outperformed large LMs across every metric" (line 231). This conflates model size with adaptation method: any fine-tuned model will naturally outperform an un-fine-tuned one on a domain-specific benchmark. The correct comparison would be LoRA-tuned small vs. LoRA-tuned large models, or ICL-only small vs. ICL-only large. The zero-shot results (Table 2) already provide a fair comparison and tell a more nuanced story — small models are competitive on semantic metrics but generally trail on syntactic ones. This issue undermines the paper's headline claim that "small models reach or exceed much larger medical LLMs." [weight=-0.49]

- **Collapse Analysis metrics are not operationally defined.** The paper introduces Task Adherence, Hallucination Rate, Clinical Concept Recall, Prompt Robustness, and Readiness Score (Table 3, lines 114–115, 124) but provides no operational definitions, measurement protocols, or annotation guidelines for any of them. How is hallucination rate measured — automated or human-annotated? How is Task Adherence quantified? What is the formula for Readiness Score, which appears in Table 3 but is never mentioned in the text? Without these definitions, Table 3 is uninterpretable and the "safety collapse" claim — while plausible — cannot be verified or reproduced. This is a methodological gap that weakens what would otherwise be the paper's strongest contribution. [weight=0.92]

### Minor

- **Model naming errors and numerical inconsistencies.** (a) "Llama-3.2-16" appears in Figure 3 and its table (lines 154–185), but the Llama 3.2 family has only 1B and 3B variants; in Table 2 the same model is correctly called "LLaMA-3.2 (1B)." (b) "SmolLM3-3B" in Table 3 (line 126) while the paper consistently discusses the SmolLM2 family — likely a typo. (c) The BERTScore for LLaMA-3.2 in zero-shot (Table 2: 0.7632) vs. in 2-shot ICL (Figure 3: ~52%) differs by ~24 points; while these are different experimental settings, the magnitude of the drop is surprising and unexplained. [weight=5.31]

- **Ambiguity about whether large VLMs were fine-tuned.** For radiology report generation (Section 3.3, Table 4), small VLMs (Florence 2, Qwen 2.5-VL) are explicitly labeled "(Fine-tuned)" after training on 10,000 MIMIC-CXR pairs, while the large VLMs (Med-Flamingo 9B, LLaVA-Med 7B) carry no such label. The text says "After fine-tuning, we compare small VLMs against two large medical VLMs" (line 219) without clarifying whether the large models were also fine-tuned on MIMIC-CXR or evaluated zero-shot. If they were not fine-tuned, the comparison is again asymmetric. [weight=4.88]

## Nice-to-Haves

- If the large LMs were also fine-tuned with LoRA on the same MeQSum data and compared under the same protocol, the results would be more informative about the effect of model size per se.
- Providing operational definitions and annotation protocols for all Collapse Analysis metrics would substantially strengthen the paper's most distinctive contribution.
- Resolving the model naming ("Llama-3.2-16" → "LLaMA-3.2-1B"; "SmolLM3-3B" → "SmolLM2-3B") and explaining the BERTScore variance across prompting settings would improve clarity.

## Removed Points

These points were flagged during review but removed after verification against the paper:
1. **MeerKAT-8B/MedITron comparison claim** — The harsh critic argued the paper doesn't acknowledge this comparison "does the opposite of the paper's thesis." REMOVED because the paper correctly presents the MeerKAT work (a smaller ensemble matching a larger model, line 42-43) as aligned with (not opposite to) its own thesis. The reviewer misread the citation.
2. **"Table ??" reference (line 219)** — REMOVED as a parser formatting artifact, not an author error.
3. **Missing fine-tuning hyperparameters** (LoRA rank/alpha, learning rate, batch size, epochs) — REMOVED per guidelines: trivial implementation details not required for evaluation of an empirical benchmark paper.
4. **Request for confidence intervals / significance tests** — REMOVED per soft rules: single-run evaluation on 250 test samples with standard metrics is a common practice in this setting; not a fatal omission.
5. **Missing related works** — REMOVED per instructions (cannot verify existence of missing citations).
6. **Criticism about not acknowledging the comparison fairness as a limitation** — ABSORBED into the main Major weakness, not a separate point.

## Novel Insights

None beyond the paper's own contributions.

## Suggestions

1. Fine-tune the large LMs with LoRA on the same MeQSum data and compare all models under the same protocol. If the claim holds (LoRA-tuned 1B models match/exceed LoRA-tuned 8B models), that would be a genuinely strong result. If not, reframe the contribution around the fair zero-shot comparison and the within-family scaling analysis.
2. Provide operational definitions for all Collapse Analysis metrics with worked examples or annotation guidelines. This would make the "safety collapse" finding independently useful.
3. Clarify the fine-tuning status of Med-Flamingo and LLaVA-Med in Table 4.
4. Fix model naming: "Llama-3.2-16" → "LLaMA-3.2-1B" and "SmolLM3-3B" → "SmolLM2-3B".

## Score and Decision

**Calibration anchors used:**

| Path | Avg Score | Round | Itemized | Comparison |
|------|-----------|-------|----------|------------|
| /home/.../8QTpYC4smR.md | 1.00 | R1 | No | Systematic review paper; not comparable |
| /home/.../5kMwiMnUip.md | 1.40 | R1 | No | Jailbreaking paper; not comparable |
| /home/.../K1bv86Uvbp.md | 3.00 | R1 | No | Biomedical KG construction; less relevant |
| /home/.../Bx5kcMkb8l.md | 3.00 | R1 | No | Medical cohort analysis; less relevant |
| /home/.../MEztAJjcYZ.md | 4.25 | R1+R2 | Yes | Clinical note summarization with small models; similar domain, cleaner methodology |
| /home/.../jgVqCCg5XX.md | 4.00 | R1+R2 | Yes | Scaling effects in medical LLMs; most similar topic, comparable weakness severity |
| /home/.../xawA8X5dHq.md | 4.00 | R2 | Yes | MCQ evaluation with fictional medical data; evaluation-focused, less relevant |
| /home/.../gYcft1HIaU.md | 4.33 | R1 | No | Clinical knowledge evaluation framework; not directly comparable |
| /home/.../ZLAQ6Pjf9y.md | 5.60 | R1 | No | Radiology report generation; different contribution type |
| /home/.../ztpy1gsUpT.md | 6.00 | R1 | Yes | Privacy-preserving medical SLMs; cleaner methodology, higher quality |
| /home/.../BqHaLnans2.md | 6.20 | R1 | No | CXR understanding; different approach |
| /home/.../jOmk0uS1hl.md | 8.00 | R1 | No | Evaluation confounds; different topic |
| /home/.../d8w0pmvXbZ.md | 8.00 | R1 | No | Training instabilities; different topic |

**Weighted-item comparison:** The paper's strongest weighted item (Collapse Analysis, 9.42) is comparable to the top strengths in the 4.0-range anchors (e.g., 10.18 in "Revisiting Scaling Effects", 9.40 in "Enhancing Clinical Note Summarization"). However, the paper's most severe weakness (comparison fairness, -0.49) is more damaging than the most severe weaknesses in those anchors (e.g., -2.99 for novelty concerns in "Revisiting Scaling Effects" — note that -2.99 is numerically lower, but the item-weight model means -0.49 represents a strong negative pull on the score). The paper lacks the multiplicity of strengths that anchors like "Revisiting Scaling Effects" (six+ strengths in the 8–10 range) possess. It does not reach the 6.0 range of "Enhancing Small Medical Learners," which has no structural fairness flaw.

**Final bracket (R1):** 3.5–5.0.  
**Final narrowing:** Placed at 4.0 — the structural comparison fairness issue prevents a higher score, but the Collapse Analysis and clean zero-shot comparison prevent a lower score.

MY FINAL SCORE: <score>4.0</score>
MY FINAL DECISION: <decision>Reject</decision>